[1]
“Polypharmacy and potential drug-drug interactions among medications prescribed to chronic kidney disease patients”, Janaki Med. Coll. J. Med. Sci., vol. 9, no. 1, pp. 25–32, Jul. 2021, doi: 10.3126/jmcjms.v9i1.38047.